KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Exchange Rate Effect (2016 - 2025)

West Pharmaceutical Services' Exchange Rate Effect history spans 17 years, with the latest figure at -$500000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 97.8% year-over-year to -$500000.0; the TTM value through Dec 2025 reached $22.9 million, up 207.01%, while the annual FY2025 figure was $22.9 million, 207.01% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$500000.0 at West Pharmaceutical Services, up from -$3.6 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $38.8 million in Q4 2022 and bottomed at -$24.1 million in Q3 2022.
  • The 5-year median for Exchange Rate Effect is -$1.8 million (2021), against an average of -$665000.0.
  • The largest annual shift saw Exchange Rate Effect crashed 643.24% in 2022 before it soared 1781.82% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$2.6 million in 2021, then surged by 1592.31% to $38.8 million in 2022, then crashed by 62.63% to $14.5 million in 2023, then plummeted by 256.55% to -$22.7 million in 2024, then soared by 97.8% to -$500000.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Exchange Rate Effect are -$500000.0 (Q4 2025), -$3.6 million (Q3 2025), and $18.5 million (Q2 2025).